cAMP Antibody (High Specificity)

Product Description

cAMP Antibody (High Specificity)
Catalog number: B2010559
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 50 uL
Molecular Weight or Concentration: na
Supplied as: Serum
Applications: molecular tool in the study of G-protein Coupled Receptors (GPCR)
Storage: -20C
Keywords: Anti-cAMP Antibody
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1: Kahaly GJ, Diana T, Olivo PD. TSH RECEPTOR ANTIBODIES: RELEVANCE & UTILITY.
Endocr Pract. 2020 Jan;26(1):97-106.

2: Quijada H, Bermudez T, Kempf CL, Valera DG, Garcia AN, Camp SM, Song JH,
Franco E, Burt JK, Sun B, Mascarenhas JB, Burns K, Gaber A, Oita RC, Reyes
Hernon V, Barber C, Moreno-Vinasco L, Sun X, Cress AE, Martin D, Liu Z, Desai
AA, Natarajan V, Jacobson JR, Dudek SM, Bime C, Sammani S, Garcia JGN.
Endothelial eNAMPT amplifies pre-clinical acute lung injury: efficacy of an
eNAMPT-neutralising monoclonal antibody. Eur Respir J. 2021 May 6;57(5):2002536.

3: Garcia-Martinez LF, Raport CJ, Ojala EW, Dutzar B, Anderson K, Stewart E,
Kovacevich B, Baker B, Billgren J, Scalley-Kim M, Karasek C, Allison D, Latham
JA. Pharmacologic Characterization of ALD403, a Potent Neutralizing Humanized
Monoclonal Antibody Against the Calcitonin Gene-Related Peptide. J Pharmacol Exp
Ther. 2020 Jul;374(1):93-103.

4: Gdowski A, Ranjan A, Mukerjee A, Vishwanatha J. Development of biodegradable
nanocarriers loaded with a monoclonal antibody. Int J Mol Sci. 2015 Feb
12;16(2):3990-5.

5: Biggs EK, Liang L, Naylor J, Madalli S, Collier R, Coghlan MP, Baker DJ,
Hornigold DC, Ravn P, Reimann F, Gribble FM. Development and characterisation of
a novel glucagon like peptide-1 receptor antibody. Diabetologia. 2018
Mar;61(3):711-721.

6: Newa M, Bhandari KH, Tang L, Kalvapalle R, Suresh M, Doschak MR. Antibody-
mediated “universal” osteoclast targeting platform using calcitonin as a model
drug. Pharm Res. 2011 May;28(5):1131-43.

7: Bhudia N, Desai S, King N, Ancellin N, Grillot D, Barnes AA, Dowell SJ. G
Protein-Coupling of Adhesion GPCRs ADGRE2/EMR2 and ADGRE5/CD97, and Activation
of G Protein Signalling by an Anti-EMR2 Antibody. Sci Rep. 2020 Jan
22;10(1):1004.

8: Takayama H, Hosaka Y, Nakayama K, Shirakawa K, Naitoh K, Matsusue T,
Shinozaki M, Honda M, Yatagai Y, Kawahara T, Hirose J, Yokoyama T, Kurihara M,
Furusako S. A novel antiplatelet antibody therapy that induces cAMP-dependent
endocytosis of the GPVI/Fc receptor gamma-chain complex. J Clin Invest. 2008
May;118(5):1785-95.

9: Latif R, Mezei M, Morshed SA, Ma R, Ehrlich R, Davies TF. A Modifying
Autoantigen in Graves’ Disease. Endocrinology. 2019 May 1;160(5):1008-1020.
10: Tsugawa M, Iida S, Fujii H, Moriwaki K, Tarui S, Sugi M, Yamane R, Fujimoto
M. An enzyme-linked immunosorbent assay (ELISA) for adenosine 3′,5′-cyclic
monophosphate (cAMP) in human plasma and urine using monoclonal antibody. J
Immunoassay. 1990;11(1):49-61.

Products Related to cAMP Antibody (High Specificity): Antibodies